EUVIMEDEUVIMED entdecken
Crossref

Immunological Parameters for Assessing the In Vitro Safety and Efficacy of Allergoid Mixtures for Immunotherapy

David Calzada, Nuria Parody, Juan M Beitia, Javier Dominguez-Ortega, David Gonzalez-de-Olano, Ana Renshaw-Calderón, Cristina Osuna, Raquel Moya, Jerónimo Carnés

Journal of Investigational Allergology and Clinical Immunology · 2025

DOI: 10.18176/jiaci.1061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Investigational Allergology and Clinical Immunology, 2025. Verfasst von David Calzada und 8 weiteren Autor:innen. Beteiligte Einrichtung: R&D Unit (Allergy & Immunology), LETI Pharma, Madrid, Spain. Hauptthemen laut MEDLINE: Desensitization, Immunologic, Allergens, Allergoids. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Most patients with respiratory allergy are polyallergic. Combining different allergen extracts in the same allergen-specific immunotherapy is a common practice. However, it should be justified.

Objective

To analyze the stability, safety, and immune response of allergen extract mixtures from nonhomologous groups.

Methods

We analyzed 2 depigmented-polymerized mixture extracts (DPmixEs): cat dander–grass pollen and Alternaria alternata–grass pollen. The stability of the mixtures was investigated by studying proteolysis and degradation effects. The allergenicity and humoral and cellular immune responses of DPmixEs were also evaluated using various technical approaches, including the Bradford assay, enzyme-linked immunosorbent assay, rabbit immunization, peripheral blood mononuclear cell culture, and flow cytometry. The results were compared with those of individual depigmented-polymerized extracts (DPEs) and native mixture extracts (NmixEs).

Results

The proteolytic activity of DPmixEs was lower than that of NmixEs. The protein content of DPmixEs remained stable for 18 months, whereas that of NmixEs decreased significantly during the first month. The allergenicity of DPmixEs was similar to that of DPEs and lower than that of NmixEs. Regarding the immune response, DPmixEs induced functional specific IgG antibodies in rabbits and blocked sIgEallergen binding. Moreover, DPmixEs induced IL-10 secretion in peripheral blood mononuclear cells from polyallergic patients, improving the Treg/TH2 cell balance.

Conclusion

These findings support the use of DPmixE as a promising formulation for allergen immunotherapy, combining stability, reduced enzymatic activity, and enhanced immunological stimulation, while preserving in vitro safety and efficacy comparable to separated depigmented-polymerized extracts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Desensitization, ImmunologicAllergensAllergoidsAnimalsRabbitsHumansPollenCatsLeukocytes, MononuclearAlternariaFemaleMaleAdultImmunoglobulin GImmunoglobulin EDander

Stichwörter der Autor:innen

Allergen-specific immunotherapyAllergoidImmunomodulationMechanisms of actionMultiallergen treatmentPolyallergyTolerogenic response

Substanzen

AllergensAllergoidsImmunoglobulin GImmunoglobulin E

Autor:innen und Institutionen

  • R&D Unit (Allergy & Immunology), LETI Pharma, Madrid, Spain.
  • Hospital Universitario de Guadalajara, Madrid, Spain.
  • Department of Allergy, Hospital Universitario La Paz, Institute for Health Research (IDIPAZ), Madrid, Spain.
  • Hospital Ramón y Cajal, Madrid, Spain.
  • Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, Campus de Cantoblanco, Madrid, Spain.

Zitieren

APA

Calzada, D., Parody, N., Beitia, J. M., Dominguez-Ortega, J., Gonzalez-de-Olano, D., Renshaw-Calderón, A., Osuna, C., Moya, R., & Carnés, J. (2025). Immunological Parameters for Assessing the In Vitro Safety and Efficacy of Allergoid Mixtures for Immunotherapy. Journal of Investigational Allergology and Clinical Immunology. https://doi.org/10.18176/jiaci.1061

Vancouver

Calzada D, Parody N, Beitia JM, Dominguez-Ortega J, Gonzalez-de-Olano D, Renshaw-Calderón A, et al. Immunological Parameters for Assessing the In Vitro Safety and Efficacy of Allergoid Mixtures for Immunotherapy. Journal of Investigational Allergology and Clinical Immunology. 2025. doi:10.18176/jiaci.1061

BibTeX
@article{Calzada2025,
  author = {Calzada, David and Parody, Nuria and Beitia, Juan M and Dominguez-Ortega, Javier and Gonzalez-de-Olano, David and Renshaw-Calderón, Ana and Osuna, Cristina and Moya, Raquel and Carnés, Jerónimo},
  title = {Immunological Parameters for Assessing the In Vitro Safety and Efficacy of Allergoid Mixtures for Immunotherapy},
  journal = {Journal of Investigational Allergology and Clinical Immunology},
  year = {2025},
  doi = {10.18176/jiaci.1061}
}
Kostenlos starten →